Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biocon
Company Monitoring Page for Biocon
latest headlines for company on cafepharma
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars
,
Humira
,
AbbVie
,
rebates
,
drug pricing
,
Amgen
,
Celltrion
,
Novartis
,
Boehringer Ingelheim
,
Biocon
,
Fresenius
,
Sandoz
,
Organon
,
Coherus
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie
,
Humira
,
biosimilars
,
Boehringer Ingelheim
,
Organon
,
Samsung Bioepsis
,
Sandoz
,
Fresenius Kabi
,
Celltrion
,
Coherus Biosciences
,
Biocon
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
Endpoints
Mon, 02/13/23 - 10:02 pm
Tags:
FDA
,
Biocon
,
Viatris
,
Avastin
,
biosimilars
,
drug manufacturing
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
Tags:
M&A
,
AbbVie
,
Biocon
,
Biogen
,
Biohaven
,
GSK
,
Halozyme Therapeutics
,
Samsung Bioepis
,
UCB
,
Viatris
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
Pharmaforum
Mon, 02/28/22 - 09:20 am
Tags:
Biocon
,
India
,
Viatris
,
Mylan
,
biosimilars
,
M&A
Viatris launched two versions of its interchangeable insulin biosimilar. Why?
Fierce Pharma
Tue, 11/16/21 - 10:29 pm
Tags:
Biocon
,
Viatris
,
Semglee
,
insulin
,
biosimilars
,
diabetes
,
Sanofi
,
Lantus
How This Historic FDA Approval Benefits Viatris
Motley Fool
Wed, 08/4/21 - 10:57 am
Tags:
Viatris
,
Biocon
,
FDA
,
Semglee
,
biosimilars
,
insulin
,
diabetes
,
interchangeable biosimilars
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Tue, 09/1/20 - 10:44 am
Tags:
Biocon
,
Mylan
,
Semglee
,
generics
,
insulin
,
diabetes
,
biosimilars
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
Fri, 06/12/20 - 08:03 pm
Tags:
FDA
,
Mylan
,
Biocon
,
Semglee
,
Sanofi
,
insulin
,
Lantus
,
diabetes
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Thu, 04/2/20 - 11:58 pm
Tags:
Biocon
,
insulin
,
diabetes
,
Lantus
,
Mylan
,
drug manufacturing
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Tue, 09/3/19 - 10:24 am
Tags:
Mylan
,
Lantus
,
generics
,
Biocon
,
drug manufacturing
,
diabetes
With FDA spanking, Biocon and Mylan face new hurdle for Lantus challenger
Fierce Pharma
Mon, 07/8/19 - 10:18 pm
Tags:
FDA
,
Biocon
,
Mylan
,
Sanofi
,
Lantus
,
insulin
,
drug manufacturing
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Fierce Pharma
Fri, 10/12/18 - 12:47 pm
Tags:
Merck
,
Samsung Bioepis
,
Lantus
,
insulin
,
diabetes
,
biosimilars
,
Mylan Labs
,
Biocon
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
CP Wire
Thu, 05/3/18 - 11:11 pm
Tags:
Coherus Biosciences
,
Neulasta
,
CHS-1701
,
Mylan
,
Biocon
Thu, 05/3/18 - 02:45 pm
Tags:
Coherus Biosciences
,
Neulasta
,
CHS-1701
,
Mylan
,
Biocon
Novartis ties a new round of biosimilar development programs to a partnership deal with India’s Biocon
Endpoints
Thu, 01/18/18 - 10:35 pm
Tags:
Novartis
,
Biocon
,
drug development
,
biosimilars
FDA Approves Eighth Biosimilar, First for Cancer Drug Herceptin
RAPS.org
Sat, 12/2/17 - 11:20 am
Tags:
FDA
,
biosimilars
,
Herceptin
,
Ogivri
,
Mylan Labs
,
Biocon
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Fierce Pharma
Tue, 11/21/17 - 11:42 am
Tags:
Biocon
,
Mylan Labs
,
FDA
,
Herceptin
,
drug manufacturing
,
biologics
,
India
Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL
Fierce Pharma
Tue, 10/10/17 - 10:18 am
Tags:
Mylan Labs
,
Biocon
,
Amgen
,
Neulasta
,
CRL
,
FDA
,
biosimilars
Biocon closer to receiving nod for LatAm entry
DNA India, India
Sat, 01/24/15 - 10:08 am
Tags:
Biocon
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.